Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tianlei Ying

Showing results (1-10 of 167) with videos related to

Pageof 17
Sort By:
Current Pharmaceutical Biotechnology|August 25, 2016
New Directions for Half-Life Extension of Protein Therapeutics: The Rise of Antibody Fc Domains and FragmentsLili Wang, Tianlei Ying
Frontiers in Immunology|November 9, 2018
Editorial: Antibody Fc Engineering: Towards Better TherapeuticsCheng Lei, Rui Gong, Tianlei Ying
Acta Pharmaceutica Sinica. B|July 19, 2024
Single-domain antibodies as therapeutics for solid tumor treatmentMingkai Wang, Tianlei Ying, Yanling Wu
Viruses|June 24, 2022
Single-Domain Antibodies as Therapeutics for Respiratory RNA Virus InfectionsKeke Huang, Tianlei Ying, Yanling Wu
Frontiers in Immunology|January 13, 2018
Single-Domain Antibodies As Therapeutics against Human Viral DiseasesYanling Wu, Shibo Jiang, Tianlei Ying
Infectious Disorders Drug Targets|June 29, 2018
Recent Progress on Neutralizing Antibodies against Hepatitis B Virus and its ImplicationsBinbin Hong, Yumei Wen, Tianlei Ying
Expert Opinion on Biological Therapy|September 13, 2016
From therapeutic antibodies to chimeric antigen receptors (CARs): making better CARs based on antigen-binding domainYanling Wu, Shibo Jiang, Tianlei Ying
Antiviral Research|March 23, 2024
Progress in novel delivery technologies to improve efficacy of therapeutic antibodiesWenli Sun, Yanling Wu, Tianlei Ying
Emerging Microbes & Infections|April 27, 2017
Precision immunomedicineTianlei Ying, Yumei Wen, Dimiter S Dimitrov
Nature Biotechnology|January 9, 2016
A systems approach to HIV-1 vaccinesTianlei Ying, Ponraj Prabakaran, Dimiter S Dimitrov
Pageof 17

Showing results (1-10 of 167) with videos related to

Sort By:
Pageof 17
Current Pharmaceutical Biotechnology|August 25, 2016
New Directions for Half-Life Extension of Protein Therapeutics: The Rise of Antibody Fc Domains and FragmentsLili Wang, Tianlei Ying
Frontiers in Immunology|November 9, 2018
Editorial: Antibody Fc Engineering: Towards Better TherapeuticsCheng Lei, Rui Gong, Tianlei Ying
Acta Pharmaceutica Sinica. B|July 19, 2024
Single-domain antibodies as therapeutics for solid tumor treatmentMingkai Wang, Tianlei Ying, Yanling Wu
Viruses|June 24, 2022
Single-Domain Antibodies as Therapeutics for Respiratory RNA Virus InfectionsKeke Huang, Tianlei Ying, Yanling Wu
Frontiers in Immunology|January 13, 2018
Single-Domain Antibodies As Therapeutics against Human Viral DiseasesYanling Wu, Shibo Jiang, Tianlei Ying
Infectious Disorders Drug Targets|June 29, 2018
Recent Progress on Neutralizing Antibodies against Hepatitis B Virus and its ImplicationsBinbin Hong, Yumei Wen, Tianlei Ying
Expert Opinion on Biological Therapy|September 13, 2016
From therapeutic antibodies to chimeric antigen receptors (CARs): making better CARs based on antigen-binding domainYanling Wu, Shibo Jiang, Tianlei Ying
Antiviral Research|March 23, 2024
Progress in novel delivery technologies to improve efficacy of therapeutic antibodiesWenli Sun, Yanling Wu, Tianlei Ying
Emerging Microbes & Infections|April 27, 2017
Precision immunomedicineTianlei Ying, Yumei Wen, Dimiter S Dimitrov
Nature Biotechnology|January 9, 2016
A systems approach to HIV-1 vaccinesTianlei Ying, Ponraj Prabakaran, Dimiter S Dimitrov
Pageof 17